Rein Therapeutics, Inc. (RNTX)

CIK 1420565 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Rein Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 4, 20268-K0001193125-26-383726
Aug 27, 20268-K0001193125-26-371260
Aug 14, 2026SCHEDULE 13G0001104659-26-097425
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097114
Aug 14, 202610-Q0001193125-26-350270
Aug 13, 2026SCHEDULE 13G/A0000935836-26-000391
Jul 21, 20268-K0001193125-26-310315
Jul 14, 2026SCHEDULE 13G/A0002060757-26-000043
Jun 8, 2026DEF 14A0001193125-26-260809
Jun 8, 2026ARS0001193125-26-260814
Jun 8, 2026DEFA14A0001193125-26-260812
May 28, 2026PRE 14A0001193125-26-245389
May 28, 202640001193125-26-245832
May 15, 202610-Q0001193125-26-225352
May 13, 202640001193125-26-220718
May 8, 2026SCHEDULE 13G/A0001697316-26-000012
May 8, 2026SCHEDULE 13G0001104659-26-057607
May 7, 2026SCHEDULE 13G0002073679-26-000049
May 6, 2026SCHEDULE 13G0000935836-26-000227
May 4, 20268-K0001193125-26-204006
May 4, 2026424B50001193125-26-202429
Apr 30, 2026EFFECT9999999995-26-001417
Apr 28, 2026S-10001193125-26-187803
Apr 27, 202610-K/A0001193125-26-178787
Mar 26, 202610-K0001193125-26-126385